top of page
Need help? +33 1 76 43 14 03
Publications & Media
Scientific publications
Corrigendum to “Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients”
Source : Journal of the National Cancer Institute
Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer
Source : JAMA
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase...
Source : JAMA
Media
Lung cancer: an app to detect relapses
Source : VIVA
Read the article
Source : SantéSocial.fr
Services
Ressources
+33 1 76 43 14 03
Legal Notices Europe
Sivan Innovation
Ha-Tidhar St 5,
4366507, Ra'anana, Israël
KAPSIKUM
4 rue René Razel, 91400, Saclay, France
Sivan France
163 Quai Aulagnier, 92600 Asnières-sur-Seine
Class IIa medical device.
Customized web-based remote monitoring application for lung cancer patients.
Class IIa medical device.
Web-based remote monitoring application for the early detection of toxicity associated with cancer treatments.
Medical device
These medical devices are regulated health products that bear the CE marking in accordance with these regulations.
Legal Notices Canada
Sivan Innovation
Ha-Tidhar St 5,
4366507, Ra'anana, Israël
Class I medical device
Customized web-based remote monitoring application for lung cancer patients.
Class I medical device
Web-based remote monitoring application for the early detection of toxicity associated with cancer treatments.
bottom of page